FOLLOW US
CALL US
(718) 934 6714, 888-WCHEXPERTS
Certification under 2015 Edition

As of 2018 all eligible providers/clinicians participating in QPP or MU programs and using Electronic Health Records (EHR) systems to trigger reports for submission should use 2015 Edition certified EHR software. Those practitioners who decide to choose submission mechanism distinct from EHR should remember that to report Promoting Interoperability (former Advancing Care Information) category the use of certified EHRs is a requirement.

iSmart EHR version 2.0.0.0 is 2015 Edition compliant certified system. The EHR base modules have been successfully tested during two Wave events we hold in March and October 2017. There are some criteria which are so-called ‘Gap’ and also compliant under 2015 Edition as they were unchanged after 2014 Edition certification.

The certified criteria allow iSmart users to complete the majority of MIPS and MU measures, so the product is applicable to those participating in Quality Payment Program and Meaningful Use Incentive Program.

Drummond group

Modules tested:

170.315(a.1)

Computerized provider order entry (CPOE) – medications;

170.315(a.2)

CPOE – laboratory;

170.315(a.3)

CPOE – diagnostic imaging;

170.315(a.4)

Drug-drug, drug-allergy interaction checks for CPOE;

170.315(a.5)

Demographics;

170.315(a.6)

Problem list;

170.315(a.7)

Medication list;

170.315(a.8)

Medication allergy list;

170.315(a.9)

Clinical decision support;

170.315(a)(10)

Drug-formulary and preferred drug list checks;

170.315(a)(11)

Smoking status;

170.315(a)(12)

Family health history;

170.315(a)(13)

Patient-specific education resources;

170.315(a)(14)

Implantable device list;

170.315(b)(1)

Transitions of care;

170.315(b)(2)

Clinical information reconciliation and incorporation;

170.315(b)(6)

Data export;

170.315(c)(1)

Clinical quality measures (CQMs) – record and export;

170.315(c)(2)

CQMs – import and calculate;

170.315(c)(3)

CQMs – report;

170.315(d)(1)

Authentication, access control, authorization;

170.315(d)(2)

Auditable events and tamper-resistance;

170.315(d)(3)

Audit report(s);

170.315(d)(4)

Amendments;

170.315(d)(5)

Automatic access time-out;

170.315(d)(6)

Emergency access;

170.315(d)(7)

End-user device encryption;

170.315(d)(8)

Integrity;

170.315(d)(9)

Trusted connection;

170.315(e)(1)

View, download, and transmit to 3rd party;

170.315(e)(2)

Secure messaging;

170.315(e)(3)

Patient health information capture;

170.315(f)(1)

Transmission to immunization registries;

170.315(f)(4)

Transmission to cancer registries;

170.315(g)(2)

Automated measure calculation;

170.315(g)(3)

Safety-enhanced design;

170.315(g)(4)

Quality management system;

170.315(g)(5)

Accessibility-centered design;

170.315(g)(6)

Consolidated CDA creation performance;

170.315(g)(7)

Application access – patient selection;

170.315(g)(8)

Application access – data category request;

170.315(g)(9)

Application access – all data request;

170.315(h)(1)

Direct Project.

Clinical Quality Measures tested:

CMS 22v5

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented;

CMS 65v6

Hypertension: Improvement in Blood Pressure;

CMS 68v6

Documentation of Current Medications in the Medical Record;

CMS 69v5

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up;

CMS 122v5

Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%);

CMS 123v5

Diabetes: Foot Exam;

CMS 125v5

Breast Cancer Screening;

CMS 128v5

Anti-depressant Medication Management;

CMS 130v5

Colorectal Cancer Screening;

CMS 134v5

Diabetes: Medical Attention for Nephropathy;

CMS 138v5

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention;

CMS 139v5

Falls: Screening for Future Fall Risk;

CMS 147v6

Preventive Care and Screening: Influenza Immunization;

CMS 149v5

Dementia: Cognitive Assessment;

CMS 156v5

Use of High-Risk Medications in the Elderly;

CMS 159v5

Depression Remission at Twelve Months;

CMS 161v5

Adult Major Depressive Disorder (MDD): Suicide Risk Assessment;

CMS 164v5

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic;

CMS 165v5

Controlling High Blood Pressure;

CMS 166v6

Use of Imaging Studies for Low Back Pain.

Drummond group
Start using iSmart system today!
TRY 1-MONTH FREE
(718) 934 6714
888-WCHEXPERTS
Address:

3047 Avenue U Brooklyn, NY 11229